; (2) ensuring the availability of surge capacity for purposes of responding to such biological agents; (3) supporting information-sharing between, and the dissemination of findings to, researchers and other relevant individuals to facilitate collaboration between industry and academia; and (4) providing, as appropriate and applicable, technical assistance and training to researchers and other relevant individuals to support the biomedical research workforce in improving the management and mitigation of safety and security risks in the conduct of research involving such biological agents. (b) Requirements As a condition of receiving a grant under this section, a regional biocontainment laboratory shall agree— (1) to such oversight activities as the Secretary determines appropriate, including periodic meetings with relevant officials of the Department of Health and Human Services, facility inspections, and other activities as necessary and appropriate to ensure compliance with the terms and conditions of such award; and (2) to report accidents, near-accidents, or other safety incidents involving biological agents and toxins into the no-fault reporting system established pursuant to section 351B of the Public Health Service Act, as added by section 402. (c) Board The Secretary shall establish a Board consisting of a representative from each entity in receipt of an award under subsection (a), which shall be headed by an executive committee of 3 members elected upon an affirmative vote from a majority of such representatives. The Board shall make recommendations to the Secretary in administering awards under this section, for purposes of— (1) improving the quality and consistency of applicable procedures and practices within laboratories funded pursuant to subsection (a)